Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Antioxidative and Hepatoprotective Effect of Corchorus depressus L. Against CCl4-induced Toxicity in Rats

    wadmin2By wadmin2August 21, 2013Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Anil Pareek*a, Sandeep Kumar Yadava, Prashant Deasaia, Ashok Godavarthib and Badri Prakash Nagoria
    aLachoo Memorial College of Science & Technology (Autonomous), Pharmacy wing, Jodhpur – 342003 (Rajasthan), INDIA.
    bRadiant Research Services Pvt. Ltd., Bangalore – 560 050, INDIA.

    Pharmacognosy Communications,2013,3,3,22-28.
    DOI:10.5530/pc.2013.3.5
    Published:August 2013
    Type:Research Article

    ABSTRACT

    Aims: The study aimed to evaluate the antioxidant and hepatoprotective activity of an ethanolic extract from Corchorus depressus (CDEE). Materials and Methods: The total phenolic and flavonoid content of CDEE was determined using standard curve of gallic acid and quercetin respectively. In vitro antioxidant activity was determined by 2,2-diphenyl-1-picryl hydrazyl (DPPH) and 2,2’-azino-bis (3-ethylbenzo-thiazoline-6-sμlfonic acid) diammonium salt (ABTS) radicals and hydrogen peroxide methods. CDEE was administered orally (200 mg, 400 mg.kg−1.day−1) to rats for 7 days. Silymarin was used as positive control. On the 8th day, the rats were given a single dose of CCl4 (1.0 ml/kg, i.p.) except vehicle control rats. After 24 h of CCl4 administration, plasma markers of hepatic damage, hepatic antioxidants and indices of lipid peroxidation along with microscopic evaluation of liver were assessed in control and treatment groups. Results: The CDEE possessed strong antioxidant activity in vitro. Pre-treatment of CDEE to CCl4 treated rats prevented hepatocyte damage as evidenced by estimating various biochemical parameters and histopathological observations. CDEE significantly prevented CCl4 induced elevation of aspartate aminotransferase (AST), alanine aminotransaminase (ALT), alkaline phosphatase (ALP), total bilirubin (TB) and CCl4 induced decrease in total protein (TP) level in Wistar rats. The CDEE treated rat liver anti-oxidant parameters superoxide dismutase (SOD), catalase (CAT), monodialdehyde (MDA) and glutathione (GSH) were significantly antagonized for the pro-oxidant effect of CCl4. Histopathological studies also supported the protective effect of CDEE. Conclusion: This study partially validated the folk and traditional use of snail in liver disorder through CCl4-induced rat experimental model.

    Keywords: ABTS, Antioxidant, Corchorus depressus, CCl4, DPPH, Hepatoprotective.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up